Skip to main content

Closed

SMMT: Summit Therapeutics Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

4thpctl

Volume

0.72×avg

Market Cap

10.11BUSD

P/E Ratio

-11.6TTM

Div Yield

-ann

Summit Therapeutics Inc.

SMMTNASDAQ Global Market·USD·Closed

Summit Therapeutics Inc.

SMMTNASDAQ·USD·Closed

$13.02

−3.12%

$13.02

−$0.42 (3.12%)

52W Range

4thpctl

Volume

0.72×avg

Mkt Cap

10.11BUSD

P/E

-11.6TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings